These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 22549550)
1. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis. Thacker SG; Zhao W; Smith CK; Luo W; Wang H; Vivekanandan-Giri A; Rabquer BJ; Koch AE; Pennathur S; Davidson A; Eitzman DT; Kaplan MJ Arthritis Rheum; 2012 Sep; 64(9):2975-85. PubMed ID: 22549550 [TBL] [Abstract][Full Text] [Related]
2. Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL/6 mice deficient in both apolipoprotein E and Fas ligand. Geng L; Wang S; Li X; Wang D; Chen H; Chen J; Sun Y; Chen W; Yao G; Gao X; Chen W; Shi S; Feng X; Sun L Curr Res Transl Med; 2018 Sep; 66(3):71-82. PubMed ID: 30108025 [TBL] [Abstract][Full Text] [Related]
3. Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus. Mohan S; Barsalou J; Bradley TJ; Slorach C; Reynolds JA; Hasni S; Thompson B; Ng L; Levy D; Silverman E; Kaplan MJ Arthritis Rheumatol; 2015 May; 67(8):2257-62. PubMed ID: 25891295 [TBL] [Abstract][Full Text] [Related]
4. Endothelial cell injury is involved in atherosclerosis and lupus symptoms in gld.apoE Yao G; Qi J; Zhang Z; Huang S; Geng L; Li W; Chen W; Tang X; Wang S; Sun L Int J Rheum Dis; 2019 Mar; 22(3):488-496. PubMed ID: 30575313 [TBL] [Abstract][Full Text] [Related]
5. Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells. Thacker SG; Duquaine D; Park J; Kaplan MJ Lupus; 2010 Mar; 19(3):288-99. PubMed ID: 20068018 [TBL] [Abstract][Full Text] [Related]
6. Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus. Reynolds JA; Rosenberg AZ; Smith CK; Sergeant JC; Rice GI; Briggs TA; Bruce IN; Kaplan MJ Arthritis Rheumatol; 2016 Dec; 68(12):2929-2935. PubMed ID: 27390112 [TBL] [Abstract][Full Text] [Related]
7. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus. Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382 [TBL] [Abstract][Full Text] [Related]
8. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691 [TBL] [Abstract][Full Text] [Related]
9. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction. Thacker SG; Berthier CC; Mattinzoli D; Rastaldi MP; Kretzler M; Kaplan MJ J Immunol; 2010 Oct; 185(7):4457-69. PubMed ID: 20805419 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. Agrawal H; Jacob N; Carreras E; Bajana S; Putterman C; Turner S; Neas B; Mathian A; Koss MN; Stohl W; Kovats S; Jacob CO J Immunol; 2009 Nov; 183(9):6021-9. PubMed ID: 19812195 [TBL] [Abstract][Full Text] [Related]
11. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. Zhao W; Thacker SG; Hodgin JB; Zhang H; Wang JH; Park JL; Randolph A; Somers EC; Pennathur S; Kretzler M; Brosius FC; Kaplan MJ J Immunol; 2009 Aug; 183(4):2729-40. PubMed ID: 19620300 [TBL] [Abstract][Full Text] [Related]
12. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. Kahlenberg JM; Thacker SG; Berthier CC; Cohen CD; Kretzler M; Kaplan MJ J Immunol; 2011 Dec; 187(11):6143-56. PubMed ID: 22058412 [TBL] [Abstract][Full Text] [Related]
14. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients. Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325 [TBL] [Abstract][Full Text] [Related]
15. Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Cederholm A; Frostegård J Ann N Y Acad Sci; 2007 Jun; 1108():96-103. PubMed ID: 17893975 [TBL] [Abstract][Full Text] [Related]
16. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898 [TBL] [Abstract][Full Text] [Related]
17. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities. Mauro D; Nerviani A Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419 [TBL] [Abstract][Full Text] [Related]
19. The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus. Richez C; Richards RJ; Duffau P; Weitzner Z; Andry CD; Rifkin IR; Aprahamian T PLoS One; 2013; 8(4):e61042. PubMed ID: 23577189 [TBL] [Abstract][Full Text] [Related]
20. Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench. Von Feldt JM Bull NYU Hosp Jt Dis; 2008; 66(3):184-7. PubMed ID: 18937629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]